Leon O. Moulder's most recent trade in Zenas Biopharma Inc. was a trade of 25,000 Common Stock done at an average price of $6.7 . Disclosure was reported to the exchange on Feb. 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Zenas Biopharma Inc. | Leon Moulder O. | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.67 per share. | 18 Feb 2025 | 25,000 | 266,155 | - | 6.7 | 166,750 | Common Stock |
Zai Lab Limited - ADR | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 21,253 | 61,771 (0%) | 0% | 0 | American Depositary Shares | |
Dianthus Therapeutics Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
Dianthus Therapeutics Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 12.00 per share. | 22 Jan 2024 | 166,667 | 1,436,745 | - | 12 | 2,000,004 | Common Stock |
Trevena Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 13,700 | 13,700 | - | - | Stock Option (Right to Buy) | |
Trevena Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Trevena Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 68,577 | 68,577 | - | - | Stock Option (Right to Buy) | |
Trevena Inc | Leon O. Moulder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2020 | 64,103 | 64,103 | - | - | Stock Option (Right to Buy) |